5/14
08:06 am
alt
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
5/10
12:32 pm
alt
Rating for ALT
Low
Report
Rating for ALT
5/10
12:32 pm
alt
Rating for ALT
Low
Report
Rating for ALT
4/29
07:25 am
alt
Altimmune, Inc. (NASDAQ: ALT) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Medium
Report
Altimmune, Inc. (NASDAQ: ALT) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
4/29
07:25 am
alt
Altimmune, Inc. (NASDAQ: ALT) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Medium
Report
Altimmune, Inc. (NASDAQ: ALT) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
4/29
06:40 am
alt
Rating for ALT
Medium
Report
Rating for ALT
4/29
06:40 am
alt
Rating for ALT
Medium
Report
Rating for ALT